Ann Arbor, MI, United States of America

Rhonda Marie Crosson

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rhonda Marie Crosson. Retrieved from https://idiyas.com/inventor/rhonda-marie-crosson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rhonda Marie Crosson: Innovator in Pharmaceutical Science

Introduction

Rhonda Marie Crosson is a notable inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of selective inhibitors for cyclooxygenase-2 (COX-2). Her work is essential in addressing inflammation and pain relief in mammals.

Latest Patents

Rhonda holds a patent for "Selective inhibitors of cyclooxygenase-2." This invention relates to COX-2 selective inhibitors that are particularly useful in treating inflammation and associated disorders, such as rheumatoid arthritis and osteoarthritis. The pharmaceutical compositions she developed are aimed at alleviating pain, especially pain related to surgery or trauma in felines and canines.

Career Highlights

Rhonda is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her role at Pfizer allows her to contribute to innovative solutions in medicine, enhancing the quality of life for many patients.

Collaborations

Rhonda has collaborated with talented professionals such as Kristin Lundy DeMello and Brian S Bronk. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Rhonda Marie Crosson exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Pfizer Corporation highlight her commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…